
South Carolina Supreme Court Affirms the Power of State Court Receivers
DALLAS--(BUSINESS WIRE)--The South Carolina Supreme Court handed down a ruling that has major implications for asbestos litigation and insurance recovery.
'The ruling sends a clear message: companies cannot profit from doing business in the U.S. and then evade responsibility when they hurt Americans by refusing to obey court orders,' said Trey Branham, partner at Dean Omar Branham Shirley.
The state's high court affirmed sanctions against Canadian company Atlas Turner Inc., including a default judgment for refusing to provide court-ordered discovery in an attempt to shield liability in an asbestos-related death. The ruling also upheld the appointment of a receiver to pursue the company's insurance assets.
'The ruling sends a clear message: companies cannot profit from doing business in the U.S. and then evade responsibility when they hurt Americans by refusing to obey court orders,' said Trey Branham, partner at Dean Omar Branham Shirley, who, along with Theile McVey of Kassell McVey, represented the family of Melvin Welch.
Mr. Welch died in 2023 of mesothelioma, an incurable cancer that affects the lining of the lungs and is only caused by exposure to asbestos. Atlas Turner, an active company in Canada, produced and sold asbestos insulation in South Carolina, where Mr. Welch was exposed.
'Companies like Atlas and its sister company, Asbestos Corporation Limited, have, for decades, thumbed their noses at U.S. court orders, after profiting from selling poisons in South Carolina and nearly every other state. We are grateful that the South Carolina Supreme Court understood this and is holding them to the rule of law,' Mr. Branham said.
The court's opinion describes the company's conduct as 'willful' and 'contemptuous,' citing its repeated refusal to comply with court-ordered discovery. Further, the court rejects the company's argument that Canadian law prohibited compliance.
The ruling is expected to have broad consequences for future asbestos litigation, especially in cases involving defunct defendants, defendants that refuse to obey court orders and insurance assets that plaintiffs struggle to access.
'This case is about protecting the rights of Americans and making sure companies and insurers are held responsible for injuries they've caused, no matter where they are located,' Ms. McVey said.
Dean Omar Branham Shirley, LLP is a nationally recognized trial firm that handles cases across the country for individuals who have suffered catastrophic injuries or have died as a result of the irresponsible conduct of others. For more information, visit www.dobslegal.com.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Cloud Range to Showcase Cutting-Edge Cybersecurity Simulations at 2025 Gartner Security & Risk Management Summit
Industry Leader Highlights Innovations in Cyber Preparedness Training NASHVILLE, Tenn., June 09, 2025--(BUSINESS WIRE)--Cloud Range, the leading enterprise cyber range platform for reducing detection and response times thereby reducing cyber risk, today announced it will showcase its latest innovations in cyber readiness and pre-emptive preparedness at the 2025 Gartner Security & Risk Management Summit, June 9–11 in National Harbor, MD. At the summit, Cloud Range will demonstrate its latest advancements, including the award-winning Range365™ platform—a fully managed, cloud-based cyber range with customizable IT and OT/ICS environments. Range365 strengthens security teams to engage in realistic attack scenarios, directly reducing cyber risk. Additionally, Cloud Range will showcase its Performance Portal, a comprehensive learning management system (LMS) providing detailed analytics on individual and team performance, enabling targeted, continuous skill development aligned to organizational needs. "The Gartner Summit is a pivotal event that brings together the brightest minds in cybersecurity," said Debbie Gordon, CEO and Founder of Cloud Range. "As cyber threats become increasingly sophisticated, it's clear that tools and tech stacks alone are not enough. From global enterprises to top universities, organizations must recognize that people—not just technology—are at the core of cyber defense. Our mission is to ensure SOC and incident response teams are always ready through immersive, real-world training programs that provide hands-on experience, build confidence, and help ensure resilience. Our presence at the summit underscores our commitment to advancing cyber defense capabilities across industries." Cloud Range's innovative approach has garnered significant recognition, including the 2025 SC Award for Best IT Security-Related Training Program and the 2025 Global InfoSec Award for Visionary Cybersecurity Training. These accolades and others reflect the company's dedication to providing cutting-edge solutions that address the evolving needs of cybersecurity professionals. Beyond enterprise solutions, Cloud Range is actively involved in shaping the future of cybersecurity education. Through collaborations with initiatives like IBM's Cyber Campus and partnerships with organizations such as Cyviz, Cloud Range is integrating its simulation technology into academic curricula, providing students with practical, real-world skills and experience to bridge the gap between theoretical knowledge and real-world application. It's a true redefinition of the student journey. For more information about Cloud Range's offerings or to schedule a demonstration at the Gartner Security & Risk Management Summit, visit: About Cloud Range Cloud Range is the first cyber Range-as-a-Service, delivering fully customizable cyberattack simulation training to prepare security teams for real-world threats. Trusted by enterprise SOCs, MSSPs, government agencies, higher education institutions, utilities, and critical infrastructure, Cloud Range helps organizations accelerate cyber defense skills and reduce risk. With Cloud Range's immersive, on-demand platform, customers can train teams, assess talent, onboard new hires, and upskill cybersecurity professionals—without needing costly physical labs or red teams. Recent recognition includes the 2025 SC Award for Best IT Security Training Program, the 2025 Global InfoSec Award for Visionary in Cybersecurity Training, the CISO Choice Award, and more. Stay ahead of threats with hands-on cyber readiness. Explore Cloud Range at View source version on Contacts Media Contact Leslie KesselringKesselring Communications for Cloud Rangeleslie@ 503-358-1012 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Yahoo
16 minutes ago
- Yahoo
Canada to hit NATO defense target early - The Globe and Mail
-- Prime Minister Mark Carney is preparing to announce Canada's largest increase in defense spending since World War II, a move that will accelerate the country's alignment with NATO's military investment targets. According to The Globe and Mail, the spending surge will enable Ottawa to hit the 2% of GDP threshold this fiscal year, years ahead of the previous government timeline. The policy shift is expected to be detailed during a speech Monday at the University of Toronto's Munk School of Global Affairs, where Mr. Carney will unveil a wide-ranging defense and security investment plan. Two senior government officials told The Globe and Mail that the initiative will include rapid procurement of military equipment and technology aimed at strengthening Canadian sovereignty and NATO obligations. The spending increase, reportedly amounting to tens of billions of dollars, marks a dramatic change from earlier federal projections that targeted 2032 as a realistic timeframe for achieving the NATO benchmark. The measures come amid mounting geopolitical tensions and criticism from allies that Canada has not kept pace with global defense commitments. In a recent report, NATO estimated Canadian defense spending at 1.45% of GDP for 2024, still well below the alliance's current 2% target. The U.S., particularly during Donald Trump's presidency, has often pressed Canada and other members to increase their military outlays, accusing allies of under-contributing to collective defense. The proposed investment will cover a broad range of priorities, including improved compensation for Armed Forces personnel, acquisition of new aircraft, drones, and Arctic monitoring systems, and upgrades to naval and air capabilities. Health care infrastructure and support for military families will also be expanded under the plan. Carney's plan is also expected to contain substantial funding to enhance domestic defense manufacturing and develop advanced technologies in cyber, artificial intelligence, space, and quantum computing. The strategy aims not only to meet NATO's current 2% guidance, but to prepare for potential future benchmarks discussed for the June 24-25 summit at The Hague that could raise the bar to 3.5% of GDP. The sudden acceleration contrasts sharply with former Prime Minister Justin Trudeau's stance, who in 2023 projected Canada wouldn't reach 2% until 2032. He had previously referred to the NATO target as a 'crass mathematical calculation,' suggesting it overlooked qualitative contributions to the alliance. Related articles Canada to hit NATO defense target early - The Globe and Mail Carney launches 'One Canadian Economy' Act to unify trade, approvals US job growth in May tops forecasts, but Macquarie warns cracks are emerging
Yahoo
18 minutes ago
- Yahoo
GoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus Pricing
Community Link allows independent pharmacies to direct contract with GoodRx, manage participation in the company's Integrated Savings Program, and access over 90 brand medication partnership offerings Cost-plus pricing is anchored on NADAC Starting July 1, all independent pharmacies will be opted out of GoodRx's Integrated Savings Program by default SANTA MONICA, Calif., June 09, 2025--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of GoodRx Community Link. Designed to address the industry challenges that independent community pharmacies face around complex reimbursement models and competitive pressures, Community Link leverages a cost-plus pricing model based on NADAC to provide predictable pricing and favorable economics. This announcement showcases GoodRx's commitment to helping independent pharmacies better manage pricing while continuing to provide consumers with affordable prices on their medications. "We know independent pharmacies are critical pillars in our communities that help millions of Americans access their medications and they need bespoke solutions to help address the industry problems they face," said Aaron Crittenden, President of Rx Marketplace at GoodRx. "GoodRx Community Link is the result of a multi-year journey to evolve the GoodRx business model and deliver solutions tailored to the specific needs of independent pharmacies. Ultimately, our goal with Community Link is to help improve the retail pharmacy business model and support a bright future for the sector." Community Link enables independent pharmacies to: Direct Contract with GoodRx: Leverages cost-plus pricing anchored on NADAC to provide independent pharmacies with direct control over pricing and favorable margins. A direct contract means the pricing relationship is entirely between GoodRx and the pharmacy, with no PBM involvement. Entering into a direct agreement with GoodRx does not waive a pharmacy's right to participate in ongoing litigation against GoodRx. Manage Participation in GoodRx's Integrated Savings Program (ISP): When a direct contract is signed, independent pharmacies will have the ability to opt-in to ISP as an additional benefit of working with GoodRx. Starting July 1, all independent pharmacies will be opted out of ISP by default. ISP participation may offer more favorable rates than traditional commercial insurance reimbursement. Access Over 90 Brand Medication Deals: A unique offering where the manufacturer buys down the price of a brand medication via GoodRx, making it more affordable for the consumer and economically beneficial for the pharmacy. Examples include Lantus, a Humira® biosimilar, and medical devices such as Dexcom. Starting today, independent pharmacies can use their NCPDP number to login to GoodRx Community Link and manage their relationship with GoodRx: To view a recording of the GoodRx Community Link webinar that was hosted last week, visit: For any questions, please reach out to: communitylink@ About GoodRx GoodRx is the leading platform for medication savings in the U.S., used by nearly 30 million consumers and over one million healthcare professionals annually. Uniquely situated at the center of the healthcare ecosystem, GoodRx connects consumers, healthcare professionals, payers, PBMs, pharma manufacturers, and retail pharmacies to make saving on medications easier. By reducing friction and inefficiencies, GoodRx helps consumers save time and money when filling prescriptions so they can get the care they deserve. Since 2011, GoodRx has helped Americans save over $85 billion on the cost of their medications. GoodRx periodically posts information that may be important to investors on its investor relations website at We intend to use our website as a means of disclosing material nonpublic information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors and potential investors are encouraged to consult GoodRx's website regularly for important information, in addition to following GoodRx's press releases, filings with the Securities and Exchange Commission (the "SEC") and public conference calls and webcasts. The information contained on, or that may be accessed through, GoodRx's website is not incorporated by reference into, and is not a part of, this press release. GoodRx Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding anticipated savings, convenience and accessibility; the expected benefits and value of GoodRx Community Link and our Integrated Savings Programs; and our plans, expectations and objectives. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, risks relating to our ability to achieve broad market education and change consumer purchasing habits; changes in medication pricing and pricing structures; our reliance on a limited number of industry participants; and the important factors discussed under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024, and our other filings with the SEC. Any such forward-looking statements are based on current expectations, projections and estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. View source version on Contacts Media Contact press@ Sign in to access your portfolio